Preschoolers can be smarter than college students at figuring out how unusual toys and gadgets work because they're more flexible and less biased than adults in their ideas about cause and effect, according to new research ...
Mar 6, 2014
0
0
(HealthDay)—Fewer than 50,000 people have enrolled in health insurance through the federal HealthCare.gov website, according to published reports.
Nov 12, 2013
0
0
(HealthDay)—Problems signing up for health insurance through HealthCare.gov, the federal website serving health exchanges in 36 states, are the result of design and software problems, The Wall Street Journal reported.
Oct 7, 2013
0
0
(HealthDay)—A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome.
Dec 21, 2012
1
0
When it comes to climate change, deforestation and toxic waste, the assumption has been that conservative views on these topics are intractable. But new research from the University of California, Berkeley, suggests that ...
Dec 10, 2012
4
0
COVID-19's origins remain hazy. Three years after the start of the pandemic, it's still unclear whether the coronavirus that causes the disease leaked from a lab or spread to humans from an animal.
Mar 2, 2023
0
5
China on Tuesday pushed back at renewed suggestions that the COVID-19 pandemic could have been the result of a lab leak, saying it has been "open and transparent" in the search for the virus' origins.
Feb 28, 2023
0
6
China on Monday rejected claims that the Covid-19 pandemic arose from a leak at one of its laboratories, following media reports that the US Department of Energy has determined that was the most likely cause of the outbreak.
Feb 27, 2023
0
21
US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion.
Dec 12, 2022
0
1
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Aug 7, 2022
0
4
